Helen Of Troy ((HELE)) has held its Q4 earnings call. Read on for the main highlights of the call.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Helen of Troy’s latest earnings call struck a nuanced tone, blending operational wins with clear near‑term pain. Management highlighted better‑than‑expected sales, disciplined inventory, tariff mitigation and defined targets through FY2027. Yet investors were reminded of soft demand, margin compression, and tariff‑driven volatility that will keep financial results choppy over the next few quarters.
Q4 Sales Performance vs. Expectations
Consolidated Q4 sales fell 3.3% year over year, but still landed ahead of management’s outlook. Executives framed the quarter as an “exceed expectations” performance, emphasizing that top‑line pressure was less severe than feared despite ongoing category headwinds.
Free Cash Flow and Balance Sheet Actions
Helen of Troy generated $132 million of free cash flow in fiscal 2026 even while absorbing $72 million of incremental tariff‑related cash outflows. The company then used operating cash and about $78 million from the sale of a distribution facility to pay down $112 million of debt in Q4, underscoring a focus on deleveraging.
Inventory Control
Year‑end inventory stood at $456 million, essentially flat versus last year even after absorbing $34 million of added tariff costs in stock. Management stressed sharper inventory productivity, pointing to nearly $50 million of slower‑moving items cleared in Q4 as evidence of tighter working‑capital discipline.
Strong Brand and International Performance
Olive & June stood out with 18% organic growth, contributing roughly 4.9 percentage points to its segment’s sales and reinforcing confidence in the brand’s trajectory. International revenue rose 5.4%, driven by expanded distribution, innovation, and outperformance from Revlon and Braun in targeted channels and regions.
Tariff Mitigation Progress
Tariffs reduced gross profit by $51 million for the year, but the company materially narrowed the hit to operating income. Through SKU prioritization, pricing moves, and supplier diversification, Helen of Troy cut the net impact to under $30 million and lowered cost‑of‑goods exposure to China tariffs to about 30%, with a goal of below 20% by FY2027.
Supply Chain and Sourcing Improvements
Roughly 45% of annual product volume can now be dual‑sourced, up meaningfully as the company works to de‑risk its footprint. The capital plan calls for further diversification and $28–$32 million of capex, with a focus on innovation and shifting production away from higher‑tariff geographies.
Positive Innovation and Awards
Management spotlighted several successful launches and accolades as proof of brand health and consumer relevance. Demand for the Revlon Versa Styler topped expectations, while Hydro Flask expansions and OXO’s Rapid Brewer, along with multiple beauty awards, supported the narrative that innovation is gaining shelf and consumer traction.
Year‑over‑Year Revenue Declines in Segments
Both major divisions posted declines, underscoring the pressure beneath the headline beats. Home & Outdoor sales slipped 1.5%, and Beauty & Wellness fell 4.7%, with management noting that roughly 2.8 percentage points of the Beauty & Wellness decline stemmed from tariff‑related disruption.
Material Margin Compression
Profitability took a notable hit as gross margin fell 400 basis points to 44.6%, while adjusted operating margin dropped 710 basis points to 8.3%. The company cited a mix of higher tariffs, worse inventory obsolescence, heavier promotional and trade spending, and an unfavorable channel mix as key drivers.
Higher SG&A and Incentive Costs
Selling, general, and administrative expenses rose faster than sales, pushing the SG&A ratio up 270 basis points year over year. Management pointed to weaker operating leverage, higher annual incentive compensation, regulatory compliance costs, and acquisition‑related spending linked to Olive & June as the main contributors.
Tariff Headwinds and Cash Outflows
Tariffs remained a heavy drag, with a $51 million gross profit impact and $72 million in incremental tariff cash outflows in fiscal 2026. Looking ahead, management warned that the first half of FY2027 will still absorb higher average tariff costs in cost of goods, pressuring near‑term earnings per share even as mitigation actions ramp.
Leverage and EBITDA Pressure
Despite paying down debt, Helen of Troy’s net leverage rose to 3.87x from 3.77x the prior quarter, reflecting lower trailing twelve‑month EBITDA and higher average tariffs. The company continues to frame deleveraging as a priority but acknowledged that earnings pressure is temporarily masking progress.
Soft Consumer Demand in Wellness and Macro Uncertainty
Beauty & Wellness trends remained soft, hurt by a mild flu and cold season that reduced demand for certain health‑related products and by heightened competitive promotions. Management also flagged broader macro risks, including inflation, freight and resin volatility, and geopolitical tensions, noting that not all of these potential shocks are embedded in guidance.
Cautious Near‑Term Outlook and Lumpy Cadence
Executives described the FY2027 trajectory as uneven, with slightly positive sales in the first half and slightly negative in the second half at the midpoint of guidance. Only about 15% of adjusted EPS is expected in the first half and Q1 is projected to be roughly breakeven, as tariff cycling and stepped‑up investments weigh on early‑year profitability.
Temporary Distribution and Shipment Disruption
To enforce consistent pricing strategies, Helen of Troy temporarily halted shipments in some Beauty & Wellness channels, signaling friction with certain retail partners. Management said shipments have largely resumed, portraying the disruption as a short‑term tradeoff to protect long‑term brand positioning and pricing integrity.
Forward‑Looking Guidance and Multi‑Year Targets
For fiscal 2027, the company guided net sales to $1.751–$1.822 billion, adjusted EBITDA to $190–$197 million, adjusted EPS to $3.25–$3.75, and free cash flow to $85–$100 million. Guidance assumes current tariff structures, steady FX, interest expense near the high‑40s, and a deliberate uptick in growth investments, with management targeting net leverage of roughly 3.2x or better by year‑end as supply‑chain diversification and tariff mitigation further take hold.
Helen of Troy’s call painted a picture of a business in transition, absorbing tariffs and macro crosswinds while shoring up its brands, supply chain and balance sheet. Investors will need to stomach near‑term margin and earnings volatility, but the company argues that disciplined cash generation, innovation, and diversification set up a healthier, less tariff‑exposed profile by FY2027.

